Annual Total Long Term Liabilities
$5.33 M
+$4.92 M+1193.45%
December 31, 2023
Summary
- As of March 10, 2025, MBRX annual total long term liabilities is $5.33 million, with the most recent change of +$4.92 million (+1193.45%) on December 31, 2023.
- During the last 3 years, MBRX annual total long term liabilities has fallen by -$3.02 million (-36.19%).
- MBRX annual total long term liabilities is now -36.19% below its all-time high of $8.35 million, reached on December 31, 2020.
Performance
MBRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$10.32 M
+$8.20 M+385.97%
September 30, 2024
Summary
- As of March 10, 2025, MBRX quarterly total long term liabilities is $10.32 million, with the most recent change of +$8.20 million (+385.97%) on September 30, 2024.
- Over the past year, MBRX quarterly long term liabilities has stayed the same.
- MBRX quarterly long term liabilities is now -14.07% below its all-time high of $12.01 million, reached on June 30, 2020.
Performance
MBRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
MBRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1193.5% | 0.0% |
| 3 y3 years | -36.2% | +3422.9% |
| 5 y5 years | +271.4% | +3422.9% |
MBRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1193.5% | at high | +3422.9% |
| 5 y | 5-year | -36.2% | +1193.5% | -14.1% | +3422.9% |
| alltime | all time | -36.2% | -100.0% | -14.1% | -100.0% |
Moleculin Biotech Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.32 M(+386.0%) |
| Jun 2024 | - | $2.12 M(-44.8%) |
| Mar 2024 | - | $3.85 M(-27.8%) |
| Dec 2023 | $5.33 M(+1193.4%) | $5.33 M(+972.2%) |
| Sep 2023 | - | $497.00 K(+69.6%) |
| Jun 2023 | - | $293.00 K(-15.3%) |
| Mar 2023 | - | $346.00 K(-16.0%) |
| Dec 2022 | $412.00 K(-72.1%) | $412.00 K(-30.5%) |
| Sep 2022 | - | $593.00 K(-42.8%) |
| Jun 2022 | - | $1.04 M(-20.4%) |
| Mar 2022 | - | $1.30 M(-11.7%) |
| Dec 2021 | $1.48 M(-82.3%) | $1.48 M(-61.1%) |
| Sep 2021 | - | $3.79 M(-30.9%) |
| Jun 2021 | - | $5.48 M(-18.0%) |
| Mar 2021 | - | $6.69 M(-19.9%) |
| Dec 2020 | $8.35 M | $8.35 M(-9.6%) |
| Sep 2020 | - | $9.24 M(-23.1%) |
| Jun 2020 | - | $12.01 M(+73.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $6.95 M(+14.0%) |
| Dec 2019 | $6.09 M(+324.7%) | $6.09 M(+1904.6%) |
| Sep 2019 | - | $304.00 K(+77.8%) |
| Jun 2019 | - | $171.00 K(-5.0%) |
| Mar 2019 | - | $180.00 K(-87.5%) |
| Dec 2018 | $1.44 M(+856.7%) | $1.44 M(-48.8%) |
| Sep 2018 | - | $2.80 M(-12.5%) |
| Jun 2018 | - | $3.20 M(+25.1%) |
| Mar 2018 | - | $2.56 M(+1606.7%) |
| Dec 2017 | $150.00 K(+70.5%) | $150.00 K(0.0%) |
| Sep 2017 | - | $150.00 K(0.0%) |
| Jun 2017 | - | $150.00 K(-92.4%) |
| Mar 2017 | - | $1.97 M(+2139.8%) |
| Dec 2016 | $88.00 K(>+9900.0%) | $88.00 K(+76.0%) |
| Sep 2016 | - | $50.00 K(-91.7%) |
| Jun 2016 | - | $600.00 K(>+9900.0%) |
| Mar 2016 | - | $0.00 |
| Dec 2015 | $0.00 | - |
FAQ
- What is Moleculin Biotech annual total long term liabilities?
- What is the all time high annual total long term liabilities for Moleculin Biotech?
- What is Moleculin Biotech annual total long term liabilities year-on-year change?
- What is Moleculin Biotech quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Moleculin Biotech?
- What is Moleculin Biotech quarterly long term liabilities year-on-year change?
What is Moleculin Biotech annual total long term liabilities?
The current annual total long term liabilities of MBRX is $5.33 M
What is the all time high annual total long term liabilities for Moleculin Biotech?
Moleculin Biotech all-time high annual total long term liabilities is $8.35 M
What is Moleculin Biotech annual total long term liabilities year-on-year change?
Over the past year, MBRX annual total long term liabilities has changed by +$4.92 M (+1193.45%)
What is Moleculin Biotech quarterly total long term liabilities?
The current quarterly long term liabilities of MBRX is $10.32 M
What is the all time high quarterly long term liabilities for Moleculin Biotech?
Moleculin Biotech all-time high quarterly total long term liabilities is $12.01 M
What is Moleculin Biotech quarterly long term liabilities year-on-year change?
Over the past year, MBRX quarterly total long term liabilities has changed by $0.00 (0.00%)